Becton Dickinson Reaches Proposed Settlement in Derivative Case

Becton Dickinson ( (BDX) ) just unveiled an announcement.

Becton, Dickinson and Company (BD) is involved in a legal matter concerning stockholder derivative actions. A proposed settlement has been reached in the consolidated stockholder derivative litigation against BD and certain of its officers and directors, which alleges breaches of fiduciary duties and other misconduct related to the Alaris infusion pump system. The settlement, if approved by the court, will resolve the litigation and prevent further claims related to the issues. A settlement hearing is scheduled for August 11, 2025, to determine the fairness of the settlement terms.

The most recent analyst rating on (BDX) stock is a Buy with a $280.00 price target. To see the full list of analyst forecasts on Becton Dickinson stock, see the BDX Stock Forecast page.

Spark’s Take on BDX Stock

According to Spark, TipRanks’ AI Analyst, BDX is a Neutral.

Becton Dickinson’s overall stock score reflects a solid financial foundation with strong revenue and cash flow management. However, technical indicators show bearish trends, and valuation metrics suggest the stock is relatively expensive. Earnings call insights and strategic business separation plans provide a mixed outlook, with both opportunities and challenges ahead.

To see Spark’s full report on BDX stock, click here.

More about Becton Dickinson

Average Trading Volume: 2,939,243

Technical Sentiment Signal: Sell

Current Market Cap: $49.36B

Learn more about BDX stock on TipRanks’ Stock Analysis page.